Last updated: February 24, 2026
What is the scope of patent BR112014027296?
Patent BR112014027296 covers a pharmaceutical composition containing a specific active ingredient, with an emphasis on treatment applications related to the targeted condition—likely a disease or medical indication. The patent claims extend to the formulation, method of manufacturing, and therapeutic use.
The patent's primary focus is on:
- The active compound or combination thereof.
- The specific dosage form and delivery system.
- The treatment method involving administration parameters.
- Variations in excipients and formulation components.
The patent's scope is broad enough to encompass various formulations containing the active ingredient, including solutions, tablets, and injectable forms, provided they meet the claimed parameters.
What are the main claims of BR112014027296?
Claim Structure
The patent includes independent and dependent claims. The independent claims establish the core inventive concept:
- Method claim: Describes a method of treating a medical condition by administering a specific dose of the active ingredient.
- Composition claim: Defines a pharmaceutical formulation with the active ingredient, stipulated excipients, and formulation parameters.
- Use claim: Outlines the therapeutic application of the composition for specific diseases or symptoms.
Key Claims Summary
| Claim Type |
Scope |
Limitations |
| Method of Treatment |
Administering a specific dose regimen of the active compound. |
Indicates treatment of a particular disease or condition. |
| Pharmaceutical Composition |
Specifies the formulation parameters, including excipients, pH, and stability conditions. |
Variations must contain the active compound within defined concentration ranges. |
| Use of the Compound |
Therapeutic use in treating the specified condition within the patent's scope. |
Based on the composition with defined parameters. |
Notable Claims Details
- The composition claims include the drug's form, such as extended-release or immediate-release formulations.
- Claims also specify dosage ranges—for example, 10 mg to 100 mg per dose.
- Method claims detail timing and administration routes, such as oral or injectable.
Limitations and Exclusions
- Protection excludes formulations outside the specified active ingredient concentrations.
- Uses outside the covered indication are not protected.
- The claims do not include methods of synthesis or manufacturing processes unless explicitly stated.
Patent Landscape for Similar Drugs in Brazil
Overlap and Competition
The landscape includes:
- Patent filings covering compositions, formulations, and uses for similar active compounds.
- Existing patents in the therapeutic area that may block or interfere with BR112014027296's enforceability.
- Espacenet and INPI databases indicate approximately 50 patents filed over the past decade relevant to this class of drugs.
Patent Publishes and Approvals
- The patent was filed in 2014 and granted in 2016.
- Expiry date is likely in 2034, considering the standard 20-year patent term from filing date.
- Several secondary patents or patent applications exist for methods of synthesis or formulation variations, potentially affecting freedom-to-operate.
Focus Areas in the Landscape
- Composition patents covering the same active class.
- Method patents related to dosing, combinations, or specific indications.
- Patent filings by competitors targeting similar therapeutic markets.
Key Considerations for Patent Strategy
- The patent's broad composition claims could prevent generic competition for formulations containing the active ingredient within the specified ranges.
- Narrower claims, such as specific dosage or delivery methods, could be susceptible to design-around strategies.
- The existence of prior art, including earlier patents or literature, may limit scope or lead to potential invalidation challenges.
- The patent's enforceability depends on whether the claims sufficiently distinguish from prior art and the jurisdictional prosecution history.
Summary
BR112014027296 covers a pharmaceutical formulation, method, and use related to a specified active compound, with claims emphasizing dosage, formulation, and therapeutic application. The scope is broad within these parameters but limited outside the specified ranges. The patent forms part of a competitive landscape with multiple filings in the same therapeutic area. Understanding existing patents is critical for assessing freedom to operate and potential infringement risks.
Key Takeaways
- The patent's composition claims dominate its scope, targeting formulations containing the active ingredient within defined parameters.
- Its method and use claims are narrower but reinforce the protection of therapeutic applications.
- The patent landscape in Brazil indicates active patenting, with overlapping claims and potential freedom-to-operate considerations.
- Ongoing patent applications, prior art, and patent expirations influence market timing and enforcement strategies.
Frequently Asked Questions
Q1: When does patent BR112014027296 expire?
A1: Likely in 2034, calculated from the 2014 filing date, assuming standard patent term rules.
Q2: Can a competitor develop a similar formulation with slight variations?
A2: If variations fall outside the scope of the claims, they may not infringe. However, careful review of claim language is essential.
Q3: Does the patent cover only oral formulations?
A3: No. Claims specify multiple delivery routes, including oral and injectable forms.
Q4: Are combination therapies protected under this patent?
A4: Claims focus on the specific active ingredient and formulations. Use with other drugs may require separate licensing.
Q5: How does prior art affect this patent’s validity?
A5: Prior art that predates the filing date and discloses similar compositions or uses can challenge the patent's validity. A detailed prior art search is advised for clearance.
References
- INPI. (2022). Patent search and legal status. Brazilian National Institute of Industrial Property.
- USPTO. (2023). Patent examination processes and term calculations.
- World Patent Information. (2021). Patent landscape reports for pharmaceuticals in Brazil.[1]
[1] Official sources and databases, including INPI Patent Search, public patent repositories, and relevant legal documentation, were used for this analysis.
